Sevasemten

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-Label Extension of EDG-5506 in Participants With Becker Muscular DystrophyNCT06066580EWTXPhase 2Enrolling by invitation2031-02Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.